Vutrisiran Disease Interactions
There are 2 disease interactions with vutrisiran.
Moderate
Vutrisiran (applies to vutrisiran) liver dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Vutrisiran has not been studied in patients with moderate or severe hepatic impairment, or in patients with prior liver transplant. Caution is advised.
References
- (2022) "Product Information. Amvuttra (vutrisiran)." Alnylam Pharmaceuticals, 1
Moderate
Vutrisiran (applies to vutrisiran) renal dysfunction
Moderate Potential Hazard, Moderate plausibility.
Vutrisiran has not been studied in patients with severe renal dysfunction, or end-stage renal disease. Caution is advised if used in these patients.
References
- (2022) "Product Information. Amvuttra (vutrisiran)." Alnylam Pharmaceuticals, 1
More about vutrisiran
- vutrisiran consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.